New research explores the potential of empagliflozin and sacubitril/valsartan as early treatment after a myocardial infarction
Researchers from ICREC-IGTP have conducted a preclinical study on the effects of the drug empagliflozin, alone or in combination with sacubitril/valsartan, in the early phase following a myocardial infarction. The combination of the two showed promising results.